top of page

Medical cannabis importer, exporter & distributor in Germany seeks equity partner

Well-established German medical cannabis distributor with sales network into German pharmacies & other global markets is seeking a strategic equity partner to fuel expansion plans. Open for full divestiture.

Listing ID:


Licence(s) Held:

Narcotics Licence, GDP Distribution Licence


Seeking strategic investment of up to €2.5 million for continued growth and market expansion

Listing Details:

  • Licensed German medical cannabis wholesaler importing, exporting & distributing a range of medicinal cannabis product forms selling in Germany, as well as other global markets

  • Currently conducting import and distribution of dried flower, extracts, finished medical cannabis products and API in bulk and jars, processing, in-house branding and white labelling services, B2B and B2C sales

  • Operating from licensed, leased premises in a commercial building, incorporating offices and lab space to support imports, as well as a partner processing and storage facility

  • Experienced, industry-leading team with deep expertise navigating German, European and global medical cannabis markets, with a firm grasp on the recreational cannabis market opportunity in Germany and the rest of Europe

  • Company has differentiated digital infrastructure and online assets providing significant competitive advantage

  • Working with an increasing number of suppliers as a “launch pad” into the German market, via white-label packaging, distribution and market access services

  • Business is self-funded, lean and efficient, operating at a low monthly burn rate with zero debts

  • The company have expanded its sourcing network and its product portfolio

  • Company is cash flow positive and expected to generate €2.7 million in 2024 and €4.5 million in 2025

  • Great opportunity to tap into German’s cannabis market as the new act came into force in 2024 that cannabis is no longer classified as a narcotic which simplifies the supply chain

  • Company can also perform research on psychedelics under the existing licences

  • Looking for a strategic partner or a merger to build on its unique platform, further scaling commercial operations and expanding to meet clientele demands in Europe

  • Open for full divestiture


Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to

bottom of page